Correlation Between Beam Therapeutics and Conduit Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Beam Therapeutics and Conduit Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beam Therapeutics and Conduit Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Beam Therapeutics and Conduit Pharmaceuticals, you can compare the effects of market volatilities on Beam Therapeutics and Conduit Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beam Therapeutics with a short position of Conduit Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beam Therapeutics and Conduit Pharmaceuticals.
Diversification Opportunities for Beam Therapeutics and Conduit Pharmaceuticals
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between Beam and Conduit is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Beam Therapeutics and Conduit Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Conduit Pharmaceuticals and Beam Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beam Therapeutics are associated (or correlated) with Conduit Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Conduit Pharmaceuticals has no effect on the direction of Beam Therapeutics i.e., Beam Therapeutics and Conduit Pharmaceuticals go up and down completely randomly.
Pair Corralation between Beam Therapeutics and Conduit Pharmaceuticals
Given the investment horizon of 90 days Beam Therapeutics is expected to under-perform the Conduit Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Beam Therapeutics is 1.35 times less risky than Conduit Pharmaceuticals. The stock trades about -0.02 of its potential returns per unit of risk. The Conduit Pharmaceuticals is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 10.00 in Conduit Pharmaceuticals on September 12, 2024 and sell it today you would lose (0.60) from holding Conduit Pharmaceuticals or give up 6.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Beam Therapeutics vs. Conduit Pharmaceuticals
Performance |
| Timeline |
| Beam Therapeutics |
| Conduit Pharmaceuticals |
Beam Therapeutics and Conduit Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Beam Therapeutics and Conduit Pharmaceuticals
The main advantage of trading using opposite Beam Therapeutics and Conduit Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beam Therapeutics position performs unexpectedly, Conduit Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Conduit Pharmaceuticals will offset losses from the drop in Conduit Pharmaceuticals' long position.| Beam Therapeutics vs. Editas Medicine | Beam Therapeutics vs. Crispr Therapeutics AG | Beam Therapeutics vs. Caribou Biosciences | Beam Therapeutics vs. Verve Therapeutics |
| Conduit Pharmaceuticals vs. Equillium | Conduit Pharmaceuticals vs. DiaMedica Therapeutics | Conduit Pharmaceuticals vs. Valneva SE ADR | Conduit Pharmaceuticals vs. Vivani Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |